Search

Displaying results 1051 - 1060 of 10000 in total
  1. Indication

    Increase in Intracranial Pressure (ICP)

    go.drugbank.com/conditions/DBCOND0113421
    Drugs: Glycerin · Sodium chloride
    Synonyms: Increase in Intracranial Pressure (ICP)
  2. Indication

    Leydig Cell Failure in Adult

    go.drugbank.com/conditions/DBCOND0081825
    Drugs: Mesterolone
    Synonyms: Leydig Cell Failure in Adult, Leydig cell failure in adult (disorder)
  3. Indication

    Burning sensation in the mouth

    go.drugbank.com/conditions/DBCOND0102063
    Drugs: Benzoic acid
    Synonyms: Discomfort in mouth, Burning sensation in the mouth
  4. Indication

    Deficiencies in enzymes of the urea cycle

    go.drugbank.com/conditions/DBCOND0023710
    Drugs: Phenylbutyric acid
    Synonyms: Deficiencies in enzymes of the urea cycle
  5. Drug

    Cefepime

    go.drugbank.com/drugs/DB01413
    ApprovedInvestigational

    Cefepime is a fourth-generation cephalosporin antibiotic developed in 1994. … [A249050] The popularity of its third-generation predecessors, its clinical efficacy, and the high prevalence of multidrug-resistant bacteria might be some of the factors leading to an increase in the

    Synonyms: (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylateCategories: Heterocyclic Compounds, 2-Ring
  6. Drug

    Cyanocobalamin

    go.drugbank.com/drugs/DB00115
    ApprovedInvestigationalNutraceutical

    Cyanocobalamin (commonly known as Vitamin B12) is a highly complex, essential vitamin, owing its name to the fact that it contains the mineral, cobalt. … This drug was initially approved by the FDA in 1942 [FDA label].

    International brands: Cobolin-M, Neuroforte-RMixtures: BION 3 FILM COATED TABLET, One A Day Tab
  7. Drug

    Satralizumab

    go.drugbank.com/drugs/DB15762
    ApprovedInvestigational

    Satralizumab is a recombinant humanized monoclonal antibody targeted against human interleukin-6 (IL-6) receptors, similar to [tocilizumab], which is produced in Chinese hamster ovary cells and based on … occurs in a pH-dependent manner[A218551] - this allows satralizumab to bind an IL-6 receptor until it reaches an endosome, after which the drug may dissociate from the receptor and move back into the

    Synonyms: Humanised anti-IL-6 receptor monoclonal antibodyCategories: Interleukin-6 Receptor Antagonist
  8. Drug

    Formoterol

    go.drugbank.com/drugs/DB00983
    ApprovedInvestigational

    Formoterol is an inhaled beta<sub>2</sub>-agonist used in the management of COPD and asthma that was first approved for use in the United States in 2001. … [L11256] It is available as a single-entity product [L10986,L11223] and in several formulations in combination with both inhaled corticosteroids [L10995,L10619] and long-acting muscarinic antagonists.

    Mixtures: FORMODUAL N. 200/6UG, FORMODUAL N. 200/6UGCategories: Cytochrome P-450 Substrates, Adrenergic beta-2 Receptor Agonists
  9. Drug

    Meperidine

    go.drugbank.com/drugs/DB00454
    ApprovedInvestigational

    A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor.

    Categories: P-glycoprotein substrates, Cytochrome P-450 SubstratesProducts: Demerol 10%-liq Im IV Sc, Demerol 75mg - Liq Im IV Sc 75mg/ml
  10. Drug

    Ferric derisomaltose

    go.drugbank.com/drugs/DB15617
    ApprovedInvestigational

    [A190528] Ferric derisomaltose is a form of iron used in the treatment of iron deficiency. This drug is a complex of iron (III) hydroxide and derisomaltose. … The latter is an iron carbohydrate oligosaccharide that works to release iron. Ferric derisomaltose was developed by Pharmacosmos Therapeutics ad was granted FDA approval in January 2020.

    Products: Monofer 100 mg/ml solution for injection/infusion in vials, Monofer 100mg/ml solution for injection/infusion in ampoules